Pharmaceutical

Madrigal seeks expedited approval for NASH treatment

Madrigal Pharmaceuticals has commenced a rolling submission of an NDA seeking expedited approval from the US FDA for resmetirom.

Jul 3, 2023 - 20:00
Madrigal seeks expedited approval for NASH treatment
Madrigal Pharmaceuticals has commenced a rolling submission of an NDA seeking expedited approval from the US FDA for resmetirom.
Read the original article

Tags:

Previous Article

Chinese NMPA approves Innovent and IASO Bio’s myeloma therapy

Next Article

Chime Biologics, Leads and Beigene enter antibody development deal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AbbVie gains FDA approval for EPKINLY in follicular lymphoma

AbbVie gains FDA approval for EPKINLY in follicular lym...

Jun 28, 2024

Could long Covid’s signs of immune dysregulation in the blood lead to a diagnostic test?

Could long Covid’s signs of immune dysregulation in the...

Jan 18, 2024

ILution travoprost by Glaukos for Open-Angle Glaucoma: Likelihood of Approval

ILution travoprost by Glaukos for Open-Angle Glaucoma: ...

Jun 20, 2024